The Accuracy of the Increased Prostate Specific Antigen Level (Greater than or Equal to 20 Ng./Ml.) in Predicting Prostate Cancer: Is Biopsy Always Required?-Reference-Cited by-同舟云学术

The Accuracy of the Increased Prostate Specific Antigen Level (Greater than or Equal to 20 Ng./Ml.) in Predicting Prostate Cancer: Is Biopsy Always Required?

Published:2002-11 Issue:5 Volume:168 Page:1990-1993
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

GERSTENBLUTH ROBERT E.¹,SEFTEL ALLEN D.¹,HAMPEL NEHEMIA¹,OEFELEIN MICHAEL G.¹,RESNICK MARTIN I.¹

Affiliation:

1. From the Cleveland Veterans Affairs Medical Center, Case Western Reserve University School of Medicine, Cleveland, Ohio

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference23 articles.

1. National trends in the epidemiology of prostate cancer, 1973 to 1994: evidence for the effectiveness of prostate-specific antigen screening;Farkas;Urology,1998

2. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate;Stamey;N Engl J Med,1987

3. Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels;Nadler;J Urol,1995

4. Prostate-specific antigen levels from completely sectioned, clinically benign, whole prostates;Brawn;Cancer,1991

5. Serum prostate specific antigen as a prescreening test for prostate cancer;Labrie;J Urol,1992

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The South African Prostate Cancer Screening Guidelines;South African Medical Journal;2024-05-09

2. Mobile Health Solutions for Prostate Cancer Diagnostics—A Systematic Review;Clinics and Practice;2023-07-28

3. Early Detection of Prostate Cancer: AUA/SUO Guideline Part II: Considerations for a Prostate Biopsy;Journal of Urology;2023-07

4. Is systematic prostate biopsy an overkill in metastatic prostate carcinoma ? A prospective validation;International Urology and Nephrology;2023-03-14

5. Evaluation of a radiomics nomogram derived from Fluoride-18 PSMA-1007 PET/CT for risk stratification in newly diagnosed prostate cancer;Frontiers in Oncology;2022-11-15